Microsatellite Instability-High, Malignant Insulinoma With Brain Metastasis

Insulinomas are the most common type of functional pancreatic neuroendocrine tumor. Although insulinomas usually are noninvasive or benign, 10% are deemed invasive or malignant. The pathologic mechanisms that lead to the malignant phenotype are not well elucidated. In this case report, we present a patient with stage 4 malignant insulinoma with metastasis to the liver, bone, and brain. Genetic analysis of the tumor showed that the tumor was mismatch-repair deficient and had a high rate of microsatellite instability. There was loss of MLH1- and PMS2-encoded protein expression, and MLH1 and MEN1 variants were identified. Notably, the liver metastasis showed considerable tumor heterogeneity (well differentiated) compared with the brain metastasis (poorly differentiated).

[1]  P. Philip,et al.  Comprehensive Genomic Profiling of Gastroenteropancreatic Neuroendocrine Neoplasms (GEP-NENs) , 2020, Clinical Cancer Research.

[2]  W. Xia,et al.  Clinical Management of Malignant Insulinoma: a single Institution’s experience over three decades , 2018, BMC Endocrine Disorders.

[3]  R. Lloyd,et al.  WHO classification of tumours of endocrine organs , 2017 .

[4]  P. Igaz,et al.  MEN1 and microRNAs: The link between sporadic pituitary, parathyroid and adrenocortical tumors? , 2017, Medical hypotheses.

[5]  P. Kunz,et al.  DNA-repair defects in pancreatic neuroendocrine tumors and potential clinical applications. , 2016, Cancer treatment reviews.

[6]  David Moher,et al.  The CARE Guidelines: Consensus-based Clinical Case Reporting Guideline Development , 2013, Journal of Medical Case Reports.

[7]  Michael A. Choti,et al.  DAXX/ATRX, MEN1, and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine Tumors , 2011, Science.

[8]  S. Beghelli,et al.  MEN1 in pancreatic endocrine tumors: analysis of gene and protein status in 169 sporadic neoplasms reveals alterations in the vast majority of cases. , 2010, Endocrine-related cancer.

[9]  A. Scarpa,et al.  Endocrine neoplasms of the pancreas: pathologic and genetic features. , 2009, Archives of pathology & laboratory medicine.

[10]  Xin Lu,et al.  Clinical implications of microsatellite instability and MLH1 gene inactivation in sporadic insulinomas. , 2009, The Journal of clinical endocrinology and metabolism.

[11]  D. Metz,et al.  Gastrointestinal neuroendocrine tumors: pancreatic endocrine tumors. , 2008, Gastroenterology.

[12]  D. Bingham,et al.  Inherited pancreatic endocrine tumor syndromes: Advances in molecular pathogenesis, diagnosis, management, and controversies , 2008, Cancer.

[13]  G. Klöppel,et al.  Hereditary neuroendocrine tumors of the gastroenteropancreatic system , 2007, Virchows Archiv.

[14]  L. Kvols,et al.  Well-Differentiated Pancreatic Nonfunctioning Tumors/Carcinoma , 2007, Neuroendocrinology.

[15]  A. Vortmeyer,et al.  Non-islet origin of pancreatic islet cell tumors. , 2004, The Journal of clinical endocrinology and metabolism.

[16]  F. Collins,et al.  Somatic mutations of the MEN1 tumor suppressor gene in sporadic gastrinomas and insulinomas. , 1997, Cancer research.

[17]  D. Ballard,et al.  Functioning insulinoma--incidence, recurrence, and long-term survival of patients: a 60-year study. , 1991, Mayo Clinic proceedings.

[18]  J. Kotzerke,et al.  Brain Metastases of a Neuroendocrine Tumor Visualized by 68Ga-DOTATATE PET/CT. , 2019, Clinical nuclear medicine.

[19]  James L. Frazier,et al.  Metastatic insulinoma to the brain , 2009 .